Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $27.8 million.

  • Sotera Health's Change in Accured Expenses rose 7853.79% to $27.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.4 million, marking a year-over-year increase of 9721.17%. This contributed to the annual value of $7.1 million for FY2024, which is 10325.71% up from last year.
  • Per Sotera Health's latest filing, its Change in Accured Expenses stood at $27.8 million for Q3 2025, which was up 7853.79% from -$4.3 million recorded in Q2 2025.
  • Sotera Health's 5-year Change in Accured Expenses high stood at $27.8 million for Q3 2025, and its period low was -$33.7 million during Q3 2023.
  • Its 5-year average for Change in Accured Expenses is $2.4 million, with a median of $8.8 million in 2023.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 429495.41% in 2021, then plummeted by 132947.73% in 2022.
  • Quarter analysis of 5 years shows Sotera Health's Change in Accured Expenses stood at $9.6 million in 2021, then skyrocketed by 134.52% to $22.5 million in 2022, then tumbled by 33.74% to $14.9 million in 2023, then crashed by 31.95% to $10.1 million in 2024, then surged by 174.31% to $27.8 million in 2025.
  • Its Change in Accured Expenses was $27.8 million in Q3 2025, compared to -$4.3 million in Q2 2025 and -$10.2 million in Q1 2025.